000 03584nam a22005175i 4500
999 _c200457842
_d76054
003 DE-He213
005 20231109085837.0
007 cr nn 008mamaa
008 220325s2022 sz | s |||| 0|eng d
020 _a9783030943837
024 7 _a10.1007/978-3-030-94383-7
_2doi
040 _aTR-AnTOB
_beng
_cTR-AnTOB
_erda
060 _aWT 155
072 7 _aMJX
_2bicssc
072 7 _aMED032000
_2bisacsh
072 7 _aMKN
_2thema
096 _aWT155EBK
245 1 0 _aPharmacological Treatment of Alzheimer's Disease
_h[electronic resource] :
_bScientific and Clinical Aspects /
_cedited by Gustavo Alves Andrade dos Santos.
250 _a1st ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _a1. Introduction -- 2. Principles of Pharmacology in Dementia -- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease -- 4. The Use of Esterase Inhibitors -- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer’s Disease -- 6. Supportive Pharmacological Treatment -- 7. Herbal Medicines and Supplements -- 8. Emergency Situations -- 9. Relationships between Treatment and Clinical Evaluations -- 10. New Perspectives for Treatment in Alzheimer's Disease.
520 _aAlzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer’s disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer’s disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer’s disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.
650 0 _aGeriatrics.
650 0 _aPharmacology.
650 0 _aPsychiatry.
650 1 4 _aGeriatrics.
650 2 4 _aPharmacology.
650 2 4 _aPsychiatry.
653 0 _aAlzheimer Disease -- drug therapy
653 0 _aAlzheimer Disease -- genetics
653 0 _aCognition -- physiology
700 1 _aSantos, Gustavo Alves Andrade dos.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
856 4 0 _uhttps://doi.org/10.1007/978-3-030-94383-7
_3Springer eBooks
_zOnline access link to the resource
942 _2NLM
_cEBK
041 _aeng